Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ValenTx, Inc.
* Single-arm, multi-center study conducted in up to 50 subjects at up to 5 sites.
* Subjects will be implanted with the EndoPass device for up to 36 months.
* Body weight, adverse events and device function will be monitored at monthly visits for the first year after implant and quarterly visits thereafter.
* Additional follow-up data will include vital signs, hip and waist circumference, blood lab tests, endoscopic and esophagram assessments of the condition of the implanted device, quality of life and eating behavior questionnaires.
* All subjects will be followed for 12 months after device removal.
* A single device renewal may take place as needed after the initial implant.
* Subject study participation may last up to four years, but is expected to vary with implant duration, which will be determined on a case-by-case basis.
Age
18–60
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
18-60 years of age.
BMI ≥ 35 and ≤ 50 kg/m2
Documented failure with non-surgical weight loss methods
Self-reported maximum and minimum body weights during the past 12 months within 10% of current body weight
You may not be if
Pregnancy or intention of becoming pregnant.
Past history of esophageal, gastric or bariatric surgery.
Medical conditions contraindicating elective endoscopic or bariatric procedures.